Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jacopo Giuliani
Observed names:
GIULIANI, JACOPO,
Giuliani, Jacopo,
J Giuliani,
J. Giuliani,
JACOPO GIULIANI
Institution:
Azienda ULSS 9 Scaligera
Observed institutions:
University of Pisa,
University of Verona,
University of Cagliari,
University of Ferrara,
Ospedale Santa Maria Annunziata,
Arcispedale Sant'Anna,
Regione del Veneto,
Ospedale SS. Annunziata,
Azienda ULSS 9 Scaligera
show all 9
ORCID:
0000-0003-4096-2514
Observed ORCID:
0000-0003-4096-2514
OpenAlex ID:
A5044009241
The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
2019
·
JACOPO GIULIANI
, ANDREA BONETTI
·
Anticancer Research
·
46
PDF
Implications of drugs with rebate in Europe
2021
·
Andrea Bonetti
, Jacopo Giuliani
·
The Lancet Regional Health - Europe
·
34
PDF
Financial Toxicity and Non-small Cell Lung Cancer Treatment: The Optimization in the Choice of Immune Check Point Inhibitors
2019
·
JACOPO GIULIANI
, ANDREA BONETTI
·
Anticancer Research
·
33
PDF
Beyond Abscopal Effect: A Meta-Analysis of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer
2021
·
Francesco Fiorica
, Umberto Tebano
, et al.
·
Cancers
·
29
PDF
Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern Italy
2021
·
Eva Pigozzi
, Daniela Tregnago
, et al.
·
PLoS ONE
·
27
PDF
Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer.
2014
·
Andrea Bonetti
, Jacopo Giuliani
, et al.
·
PubMed
·
24
Financial toxicity and cancer treatments: Help from biosimilars – The explanatory case of bevacizumab
2020
·
Jacopo Giuliani
, Francesco Fiorica
, et al.
·
European Journal of Cancer
·
23
The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials
2016
·
Jacopo Giuliani
, Andrea Bonetti
·
Clinical Colorectal Cancer
·
21
Nivolumab in Second-Line Treatment for Advanced Non–Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs
2017
·
Jacopo Giuliani
, Andrea Bonetti
·
Clinical Lung Cancer
·
19
Immune-checkpoint inhibitors in head and neck squamous cell carcinoma: cost-efficacy in second-line treatment based on programmed death-ligand 1 (PD-L1) level
2019
·
Jacopo Giuliani
, Andrea Bonetti
·
Oral Oncology
·
18
Which grade is of clinical benefit in the randomised controlled trials? The example of 54th American Society of Clinical Oncology annual meeting, 2018
2018
·
Jacopo Giuliani
, Andrea Bonetti
·
European Journal of Cancer
·
18
First-line therapies in metastatic colorectal cancer: integrating clinical benefit with the costs of drugs
2018
·
Jacopo Giuliani
, Andrea Bonetti
·
International Journal of Colorectal Disease
·
18
Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma
2018
·
Jacopo Giuliani
, Andrea Bonetti
·
Clinical Genitourinary Cancer
·
16
The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer
2020
·
Jacopo Giuliani
, Andrea Bonetti
·
Journal of Oncology Pharmacy Practice
·
15
Immunotherapy in first-line for advanced non-small cell lung cancer: a cost-effective choice?
2019
·
Jacopo Giuliani
, Andrea Bonetti
·
Recenti Progressi in Medicina
·
15
Centrosome Linker–induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers
2018
·
Andrea Remo
, Erminia Manfrin
, et al.
·
Molecular Cancer Research
·
15
The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies
2015
·
Jacopo Giuliani
, Andrea Bonetti
·
Journal of Gastrointestinal Cancer
·
15
Trends in Survival for Patients with Metastatic Breast Cancer: Is Survival Improving?
2015
·
Jacopo Giuliani
, Andrea Bonetti
·
Tumori Journal
·
15
The Onset of Grade ≥3 Neutropenia Is Associated With Longer Overall Survival in Metastatic Colorectal Cancer Patients Treated With Trifluridine/Tipiracil
2019
·
JACOPO GIULIANI
, ANDREA BONETTI
·
Anticancer Research
·
13
PDF
Gastrointestinal Stromal Tumors and Other Malignancies: a Case Series
2012
·
Jacopo Giuliani
, Marina Marzola
, et al.
·
Journal of Gastrointestinal Cancer
·
12
Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report
2018
·
Pietro Parcesepe
, Guido Giordano
, et al.
·
Pathology - Research and Practice
·
11
Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials
2024
·
Marcello Tucci
, Marta Mandarà
, et al.
·
Cancer Treatment Reviews
·
10
Cost-effectiveness of newer regimens for the prophylaxis of chemotherapy-induced nausea and vomiting: review of the literature and real-world data
2020
·
Jacopo Giuliani
, Andrea Bonetti
·
Current Opinion in Oncology
·
10
Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials
2015
·
Jacopo Giuliani
, Andrea Bonetti
·
Clinical Lung Cancer
·
10
What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations
2021
·
Paolo Bossi
, Andrea Antonuzzo
, et al.
·
Cancer Management and Research
·
9
PDF
Show more works
View as search
Works count:
170
Citation count:
763
H-index:
15
I10-index:
24
Year
Topic
Type
